This message was posted by a user wishing to remain anonymous
Greetings all,
I have encountered a situation where the sponsor has combination device where the drug is approved, but the device is not approved in Canada. What are the safety reporting requirements (guidance) for this combination product. The MOA is the drug.
Thank you for any help and suggestions.